Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by Maxmoeon Jan 10, 2025 11:01am
64 Views
Post# 36397984

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:New Press Release - Theratechnologies Provides Update on EGRIFTA SV® Supply

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:New Press Release - Theratechnologies Provides Update on EGRIFTA SV® SupplyOr....you could have sold some. I know a guy that sold some close to 52w high. Heck, nobody's perfect. He missed the top. But he's not buying back any more until the boo birds are horse voiced from the gloating. Shouldn't take too long but 35 cents is just a minor correction. He took 100% of his investment $$ off the table when the stock doubled and now still has a fair position. Or so I hear. I reminded him it doesn't really matter what price he paid, all the shares are exactly the same no matter how long you owned them or what you paid. I also reminded him if the stock IF, goes to $10 it won't matter if he paid $1.60 or $3.60. Either way that's a great return. Ditto if it goes to zero. It's -100% no matter what the starting point was. So tune out the daily/weekly noise. Where will we be at year end? He said much higher than $2.50. I said I agree. 
<< Previous
Bullboard Posts
Next >>